Norwalk Virus Infection and Disease Is Associated with ABO Histo–Blood Group Type
The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.
Abstract
Some people are resistant to Norwalk virus (NV) infection; however, the factor(s) responsible for resistance or susceptibility to NV infection has not been identified. This study investigated the relationship between a person's ABO histo-blood group type and the risk of NV infection and symptomatic disease after clinical challenge. ABO phenotypes were identified by using serum samples from volunteers who participated in an NV challenge study (n=51). Individuals with an O phenotype were more likely to be infected with NV (odds ratio [OR], 11.8; 95% confidence interval [CI], 1.3-103), whereas persons with a B histo-blood group antigen had decreased risk of infection (OR, 0.096; 95% CI, 0.16-0.56) and symptomatic disease (OR, 0; 95% CI, 0-0.999). This is the first report demonstrating an association between a genetic factor and the risk of NV infection and symptomatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The analysis of case-control studies
Breslow, N. E., & Day, N. E. (1980) · International Agency for Research on Cancer eBooks · Cited by 2,415
X-ray Crystallographic Structure of the Norwalk Virus Capsid
Prasad, B. V. V., Hardy, M. E., Dokland, T., Bella, J., Rossmann, M. G., & Estes, M. K. (1999) · Science · doi:10.1126/science.286.5438.287 · Cited by 946 · cited 1×
“We suspected that an individual’s ABO phenotype may play a role in NV susceptibility, because in recent studies [6, 7] hemagglutination by NV-like particles (VLPs), which are structurally and antigenically similar to virions, occurred in all samples of type O human red blood cells (RBCs) but in very few samples of typ…”
BackgroundSelf-citationClausen, H., & Hakomori, S. (1989) · Vox Sanguinis · doi:10.1111/j.1423-0410.1989.tb03040.x · Cited by 504 · cited 1×
“One possibility is that such uninfected individuals may not secrete ABH antigens (frequency of 20*^ among white subjects) [19].”
BackgroundClinical Immunity in Acute Gastroenteritis Caused by Norwalk Agent
Parrino, T. A., Schreiber, D. S., Trier, J. S., Kapikian, A. Z., & Blacklow, N. R. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707142970204 · Cited by 478 · cited 4×
“[2] reported that 6 of 12 individuals challenged with NV developed clinical signs of infection, including vomiting and/or diarrhea, whereas the other 6 persons were asymptomatic.”
BackgroundInfluentialFankhauser, R. L., Noel, J. S., Monroe, S. S., Ando, T., & Glass, R. I. (1998) · The Journal of Infectious Diseases · doi:10.1086/314525 · Cited by 459 · cited 1×
““Norwalk-like viruses” (NLVs) are a major cause of epidemic and sporadic cases of acute gastroenteritis in adults and children in the United States [1].”
BackgroundNorwalk Virus Infection of Volunteers: New Insights Based on Improved Assays
Graham, D. Y., Jiang, X., Tanaka, T., Opekun, A. R., Madore, H. P., & Estes, M. K. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.1.34 · Cited by 449 · cited 4×
“Thirteen of the remaining 42 infected volunteers had asymptomatic infection with an increase in NV-specific antibodies in convalescent serum samples, with or without antigen shedding, and without clinical disease [8].”
BackgroundMethodSelf-citationWyatt, R. G., Dolin, R., Blacklow, N. R., DuPont, H. L., Buscho, R. F., Thornhill, T. S., Kapikian, A. Z., & Chanock, R. M. (1974) · Journal of Infectious Diseases · doi:10.1093/infdis/129.6.709 · Cited by 360 · cited 2×
“term immunity to NV because of previous exposure to a homologous strain [4].”
BackgroundWatanabe, K., Hakomori, S. I., Childs, R. A., & Feizi, T. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50747-x · Cited by 274 · cited 1×
“protein-carbohydrate interactions has been described elsewhere for antibodies and their carbohydrate epitopes [17, 18].”
BackgroundGreen, K. Y., Lew, J. F., Jiang, X., Kapikian, A. Z., & Estes, M. K. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.8.2185-2191.1993 · Cited by 215 · cited 1×
“We suspected that an individual’s ABO phenotype may play a role in NV susceptibility, because in recent studies [6, 7] hemagglutination by NV-like particles (VLPs), which are structurally and antigenically similar to virions, occurred in all samples of type O human red blood cells (RBCs) but in very few samples of typ…”
BackgroundSelf-citationDensity of Helicobacter pylori Infection In Vivo as Assessed by Quantitative Culture and Histology
Atherton, J. C., Tham, K. T., Peek, R. M., Cover, T. L., & Blaser, M. J. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.552 · Cited by 185 · cited 1×
“pylori colonization and enhanced immune response in individuals with a type O phenotype may contribute to the preponderance of the type O phenotype among patients with duodenal ulcers [11, 12].”
Background
Research works printed but not linked: 1
- Albert MJ. Epidemiology and molecular biology of Vibrio cholerae O139 Bengal. Indian J Med Res 1996; 104:14-27.
Cited by
Items 201–300 of 494
Halperin, T., Vennema, H., Koopmans, M., Bar‐Gal, G. K., Kayouf, R., Sela, T., Ambar, R., & Klement, E. (2007) · The Journal of Infectious Diseases · doi:10.1086/524145 · Cited by 47
Matzhold, E. M., Berghold, A., Bemelmans, M. K. B., Banfi, C., Stelzl, E., Kessler, H. H., Steinmetz, I., Krause, R. G. E., Wurzer, H., Schlenke, P., et al. (2021) · Transfusion · doi:10.1111/trf.16567 · Cited by 40
Wu, S., Kamili, N. A., Dias‐Baruffi, M., Josephson, C. D., Rathgeber, M. F., Yeung, M. Y., Lane, W. J., Wang, J., Jan, H.-M., Rakoff-Nahoum, S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104482 · Cited by 40
Characterization of Blockade Antibody Responses in GII.2.1976 Snow Mountain Virus-Infected Subjects
Swanstrom, J., Lindesmith, L. C., Donaldson, E., Yount, B. L., & Baric, R. S. (2013) · Journal of Virology · doi:10.1128/jvi.02793-13 · Cited by 45
Antiviral targets of human noroviruses
Prasad, B. V. V., Shanker, S., Muhaxhiri, Z., Deng, L., Choi, J.-M., Estes, M. K., Song, Y., Palzkill, T. G., & Atmar, R. L. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.06.002 · Cited by 45
Self-citationJasim, W. E. (2012) · Eastern Mediterranean Health Journal · doi:10.26719/2012.18.8.888 · Cited by 54
Structural Analysis of a Rabbit Hemorrhagic Disease Virus Binding to Histo-Blood Group Antigens
Leuthold, M. M., Dalton, K. P., & Hansman, G. S. (2014) · Journal of Virology · doi:10.1128/jvi.02832-14 · Cited by 42
Norovirus-Specific Memory T Cell Responses in Adult Human Donors
Malm, M., Tamminen, K., Vesikari, T., & Blazevic, V. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01570 · Cited by 39
“…and gastrointestinal tract surface epithelia and in bodily secretions, are recognized and bound by NoV particles in a genotype-specific manner (Uusi-Kerttula et al., 2014) and putatively serve as the initiation site for NoV infection (Hutson et al., 2002; Huang et al., 2003; Cao et al., 2007).”
BackgroundHeterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles
Devant, J. M., Hofhaus, G., Bhella, D., & Hansman, G. S. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.05.010 · Cited by 41
Human and Animal Viruses in Food (Including Taxonomy of Enteric Viruses)
Greening, G. E., & Cannon, J. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-30723-7_2 · Cited by 39
Binding activity of norovirus and sapovirus to histo-blood group antigens
Shirato, H., Ogawa, S., Wakita, T., Takeda, N., & Hansman, G. S. (2006) · Archives of Virology · doi:10.1007/s00705-006-0883-z · Cited by 49
Norovirus Vaccines and Potential Antinorovirus Drugs: Recent Advances and Future Perspectives
Kocher, J., & Yuan, L. (2015) · Future Virology · doi:10.2217/fvl.15.57 · Cited by 38
Uusi-Kerttula, H. K., Tamminen, K., Malm, M., Vesikari, T., & Blazevic, V. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.02.010 · Cited by 39
Two Gastroenteritis Outbreaks Caused by GII Noroviruses: Host Susceptibility and HBGA Phenotypes
Jin, M., He, Y., Li, H., Huang, P., Zhong, W., Yang, H., Zhang, H., Tan, M., & Duan, Z.-J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058605 · Cited by 38
Structural basis of glycan interaction in gastroenteric viral pathogens
Prasad, B. V. V., Shanker, S., Hu, L., Choi, J.-M., Crawford, S. E., Ramani, S., Czakó, R., Atmar, R. L., & Estes, M. K. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.05.008 · Cited by 38
Self-citationArifuzzaman, M., Ahmed, T., Rahman, M. A., Chowdhury, F., Rashu, R., Khan, A. I., LaRocque, R. C., Harris, J. B., Bhuiyan, T. R., Ryan, E. T., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001413 · Cited by 38
Tian, P., Yang, D. K., Shan, L., Li, Q., Liu, D., & Wang, D. (2017) · Food and Environmental Virology · doi:10.1007/s12560-017-9317-1 · Cited by 39
Moyo, S. J., Kommedal, Ø., Blomberg, B., Hanevik, K., Tellevik, M. G., Maselle, S. Y., & Langeland, N. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx173 · Cited by 39
Holmner, Å., Mackenzie, A. M., & Krengel, U. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.050 · Cited by 41
Structural Basis of Nanobodies Targeting the Prototype Norovirus
Ruoff, K., Kilic, T., Devant, J. M., Koromyslova, A. D., Ringel, A. R., Hempelmann, A., Geiß, C., Graf, J., Haas, M., Roggenbach, I., et al. (2019) · Journal of Virology · doi:10.1128/jvi.02005-18 · Cited by 38
“Norovirus interaction with cofactor histo-blood group antigens (HBGAs) is important for infection (e.g., GI.1, GII.4, GII.10, and GII.17), although certain genotypes poorly bind HBGAs (e.g., GII.1) (5) (6) (7) (8) .”
BackgroundThe distribution of the ABO blood groups among the diabetes mellitus patients in Qatar
Bener, A., & Yousafzai, M. T. (2014) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.141418 · Cited by 36
Fondness for sugars of enteric viruses confronts them with human glycans genetic diversity
LePendu, J., & Ruvoën‐Clouet, N. (2019) · Human Genetics · doi:10.1007/s00439-019-02090-w · Cited by 41
Genotype Considerations for Virus-Like Particle-Based Bivalent Norovirus Vaccine Composition
Malm, M., Tamminen, K., Lappalainen, S., Uusi-Kerttula, H. K., Vesikari, T., & Blazevic, V. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00015-15 · Cited by 35
Guo, Y., Candelero-Rueda, R. A., Saif, L. J., & Vlasova, A. N. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009237 · Cited by 35
“Further, HBGAs are also known to act as attachment (co-)receptors/(co-)factors for multiple pathogens including noroviruses [19] and coronaviruses [20].”
BackgroundThe H Antigen at Epithelial Surfaces Is Associated with Susceptibility to Asthma Exacerbation
Innes, A. L., McGrath, K. W., Dougherty, R. H., McCulloch, C. E., Woodruff, P. G., Seibold, M. A., Okamoto, K. S., Ingmundson, K. J., Solon, M., Carrington, S. D., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0488oc · Cited by 36
Lactic Acid Bacteria (LAB) Bind to Human B- or H-Antigens Expressed on Intestinal Mucosa
Uchida, H., Kawai, Y., KINOSHITA, H., Kitazawa, H., Miura, K., Shiiba, K., Horii, A., Kimura, K., Taketomo, N., Oda, M., et al. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60407 · Cited by 34
Norovirus diagnostics: options, applications and interpretations
Kirby, A., & Iturriza‐Gómara, M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.21 · Cited by 36
Human norovirus GII.4(MI001) P dimer binds fucosylated and sialylated carbohydrates
Wegener, H., Mallagaray, Á., Schöne, T., Peters, T., Lockhauserbäumer, J., Yan, H., Uetrecht, C., Hansman, G. S., & Taube, S. (2017) · Glycobiology · doi:10.1093/glycob/cwx078 · Cited by 33
Taube, S., Kurth, A. A., & Schreier, E. (2005) · Archives of Virology · doi:10.1007/s00705-005-0517-x · Cited by 36
Gibson, K. E., D'Souza, D. H., & Hall, A. J. (2019) · ASM Press eBooks · doi:10.1128/9781555819972.ch23 · Cited by 30
Humoral immune responses against norovirus infections of children
Iritani, N., Seto, T., Hattori, H., Natori, K., Takeda, N., Kubo, H., Yamano, T., Ayata, M., Ogura, H., & Seto, Y. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20897 · Cited by 30
“Recent studies have shown that HBGA may function as receptors of NoV through outbreak investigation [Hennessy et al., 2003; Rockx et al., 2005b] and volunteer challenge studies [Hutson et al., 2002; Lindesmith et al., 2003].”
BackgroundMeyer, E., Ebner, W., Scholz, R., Dettenkofer, M., & DASCHNER, F. D. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00296-2 · Cited by 32
Role of annexin A2 in cellular entry of rabbit vesivirus
González‐Reyes, S., García-Manso, A., del Barrio, G., Dalton, K. P., González-Molleda, L., Arrojo-Fernández, J., Nicieza, I., & Parra, F. (2009) · Journal of General Virology · doi:10.1099/vir.0.013276-0 · Cited by 36
“Several cellular factors have been shown to be critical in calicivirus entry, including a2,6-linked sialic acid present on N-linked glycoproteins (Stuart & Brown, 2007) and ABH histo-blood group antigens (Hutson et al., 2002; Marionneau et al., 2002).”
BackgroundWaterborne Norovirus Outbreaks
Maunula, L. (2006) · Future Virology · doi:10.2217/17460794.2.1.101 · Cited by 33
Tan, M., & Jiang, X. (2008) · The Journal of Infectious Diseases · doi:10.1086/589810 · Cited by 30
Identification of a blockade epitope of human norovirus GII.17
Yi, Y., Wang, X., Wang, S., Xiong, P., Liu, Q., Zhang, C., Yin, F., & Huang, Z. W. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1925162 · Cited by 29
Tan, M., & Jiang, X. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28626 · Cited by 29
A Norovirus Vaccine on the Horizon?
Vinjé, J. (2010) · The Journal of Infectious Diseases · doi:10.1086/657088 · Cited by 29
Morozov, V., Hanisch, F., Wegner, K. M., & Schroten, H. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02826 · Cited by 29
Rowan, N. J. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.162380 · Cited by 30
Characterizing Norovirus Transmission from Outbreak Data, United States
Steele, M. K., Wikswo, M. E., Hall, A. J., Koelle, K., Handel, A., Lévy, K., Waller, L. A., & Lopman, B. A. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.191537 · Cited by 34
In Situ Capture RT-qPCR: A New Simple and Sensitive Method to Detect Human Norovirus in Oysters
Zhou, Z.-H., Tian, Z., Li, Q., Tian, P., Wu, Q., Wang, D., & Shi, X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00554 · Cited by 27
Current and future developments in travelers’ diarrhea therapy
Koo, H. L., & DuPont, H. L. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.3.417 · Cited by 26
Yu, J.-H., Kim, N.-Y., Lee, E. J., & Jeon, I. S. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.6.734 · Cited by 30
Norovirus genetic diversity and evolution: implications for antiviral therapy
Rocha‐Pereira, J., Dycke, J. V., & Neyts, J. H. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.09.009 · Cited by 30
Hossain, M. E., Rahman, R., Ali, S. I., Islam, M. M., Rahman, M. Z., Ahmed, S., Faruque, A. S. G., Barclay, L., Vinjé, J., & Rahman, M. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy915 · Cited by 27
Boniface, K., Byars, S., Cowley, D., Kirkwood, C. D., & Bines, J. E. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz333 · Cited by 24
Detection and characterization of porcine sapoviruses from asymptomatic animals in Irish farms
Collins, P. J., Martella, V., Buonavoglia, C., & O’Shea, H. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.05.013 · Cited by 25
Genetic heterogeneity of bovine noroviruses in Italy
Martino, B. D., Profio, F. D., Felice, E. D., Melegari, I., Ceci, C., Mauroy, A., Thiry, É., Martella, V., & Marsilio, F. (2014) · Archives of Virology · doi:10.1007/s00705-014-2109-0 · Cited by 23
Blazevic, V., Malm, M., & Vesikari, T. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24237 · Cited by 25
Affinities of human histo-blood group antigens for norovirus capsid protein complexes
Han, L., Kitova, E. N., Tan, M., Jiang, X., Pluvinage, B., Boraston, A. B., & Klassen, J. S. (2014) · Glycobiology · doi:10.1093/glycob/cwu100 · Cited by 24
“…group antigens (HBGAs), which are found on the surfaces of red blood cells andmucosal epithelial cells in the form of glycoproteins and glycolipids (Oriol 1990; Ravn and Dabelsteen 2000), as cellular receptors or attachment factors (Hutson et al. 2002, 2003; Huang et al. 2005; Tan and Jiang 2005a).”
BackgroundAssociation Between Blood Groups and COVID-19 Outcome in Iranian Patients
Ayatollahi, A. A., Aghcheli, B., Amini, A., Nikbakht, H., Ghassemzadehpirsala, P., Behboudi, E., Rajabi, A., & Tahamtan, A. (2021) · Future Virology · doi:10.2217/fvl-2021-0090 · Cited by 23
Huang, P., Morrow, A. L., & Jiang, X. (2009) · Glycoconjugate Journal · doi:10.1007/s10719-009-9229-x · Cited by 24
Inhibition of attachment of virions of Norwalk virus to mammalian cells by soluble histone molecules
Tamura, M., Natori, K., Kobayashi, M., Miyamura, T., & Takeda, N. (2003) · Archives of Virology · doi:10.1007/s00705-003-0143-4 · Cited by 28
Norovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens
Ali, E. S., Rajapaksha, H., Carr, J. M., & Petrovsky, N. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.07.006 · Cited by 26
Do Blood Group Antigens and the Red Cell Membrane Influence Human Immunodeficiency Virus Infection?
Davison, G. M., Hendrickse, H. L., & Matsha, T. E. (2020) · Cells · doi:10.3390/cells9040845 · Cited by 21
Burch, T. R. (2018) · Risk Analysis · doi:10.1111/risa.13189 · Cited by 21
Organoids to Dissect Gastrointestinal Virus–Host Interactions: What Have We Learned?
Crawford, S. E., Ramani, S., Blutt, S. E., & Estes, M. K. (2021) · Viruses · doi:10.3390/v13060999 · Cited by 22
“It is clear from many epidemiological studies that genetic factors can significantly affect susceptibility to mucosal pathogens in the intestine [63,64].”
BackgroundSelf-citationDe Masi, R., & Orlando, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137373 · Cited by 20
“In fact, noroviruses can be affected in their infection spreading as they selectively bind to one blood group of ABO structure and not another [98,99].”
BackgroundThe Molecular Virology of Enteric Viruses
Buesa, J., & Rodríguez‐Díaz, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-30723-7_3 · Cited by 23
Bai, G.-H., Tsai, M.-C., Lin, S., Hsu, Y., & Chen, S.-Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1212582 · Cited by 23
“Observational studies have also shown that individuals with blood group O (H antigen) are more likely to be infected with norovirus, while individuals with blood group B appear to have reduced susceptibility to symptomatic norovirus infection (Hutson et al., 2002; Hennessy et al., 2003).”
BackgroundLewis histo-blood group α1,3/α1,4 fucose residues may both mediate binding to GII.4 noroviruses
Nasir, W., Frank, M., Koppisetty, C. A. K., Larson, G., & Nyholm, P. (2012) · Glycobiology · doi:10.1093/glycob/cws084 · Cited by 22
Yang, B. (2012) · Open Glycoscience · doi:10.2174/1875398101205010019 · Cited by 22
Failure to detect norovirus in a large group of asymptomatic individuals
Marshall, J. A., Hellard, M. E., Sinclair, M. I., Fairley, C. K., Cox, B. J., Catton, M. G., Kelly, H., & Wright, P. J. (2004) · Public Health · doi:10.1016/j.puhe.2003.09.007 · Cited by 19
Vero Cells as a Mammalian Cell Substrate for Human Norovirus
Todd, K. V., & Tripp, R. A. (2020) · Viruses · doi:10.3390/v12040439 · Cited by 18
“W attempted to inhibit HuNoV entry into Vero cells using antibody blockade, and by saturation of potential CD300ld/CD300lf binding sites using a CD300ld/CD300lf ectodomain peptide, but both attempts were unsuccessful [51].”
BackgroundInfluentialSzymanski, J. M., Mohrmann, L., Carter, J. H., Nelson, R. C., Chekuri, S., Assa, A., Spund, B., Reyes‐Gil, M., Uehlinger, J., Baron, S. W., et al. (2021) · Transfusion · doi:10.1111/trf.16339 · Cited by 20
Yazawa, S., Yokobori, T., Ueta, G., Ide, M., Altan, B., Thongprachum, A., Nishimura, T., Nakajima, T., Kominato, Y., Asao, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089071 · Cited by 20
A Luciferase Immunoprecipitation System (LIPS) assay for profiling human norovirus antibodies
Tin, C. M., Yuan, L., Dexter, R. J., Parra, G. I., Bui, T., Green, K. Y., & Sosnovtsev, S. V. (2017) · Journal of Virological Methods · doi:10.1016/j.jviromet.2017.06.017 · Cited by 18
Long‐term viral shedding and viral genome mutation in norovirus infection
Miyoshi, T., Uchino, K., Yoshida, H., Motomura, K., Takeda, N., Matsuura, Y., & Tanaka, T. N. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24242 · Cited by 17
ABO Blood Groups and Susceptibility to Brucellosis
Mohsenpour, B., Hajibagheri, K., Afrasiabian, S., Ghaderi, E., & Ghasembegloo, S. (2014) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2014.185 · Cited by 17
Dai, Y., Nie, J., Zhang, X.-F., Li, Z., Bai, Y., Zeng, Z., Yu, S., Farkas, T., & Jiang, X. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4615-4619.2004 · Cited by 20
Norovirus vaccines: Correlates of protection, challenges and limitations
Melhem, N. M. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1125054 · Cited by 23
Zheng, Q., van Die, I., & Cummings, R. D. (2008) · Glycobiology · doi:10.1093/glycob/cwn007 · Cited by 20
Human Noroviruses Attach to Intestinal Tissues of a Broad Range of Animal Species
Villabruna, N., Schapendonk, C. M. E., Aron, G. I., Koopmans, M., & de Graaf, M. (2020) · Journal of Virology · doi:10.1128/jvi.01492-20 · Cited by 17
Higo‐Moriguchi, K., Shirato, H., Someya, Y., Kurosawa, Y., Takeda, N., & Taniguchi, K. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23734 · Cited by 16
Nudel, R., Appadurai, V., Schork, A. J., Buil, A., Bybjerg‐Grauholm, J., Børglum, A. D., Daly, M. J., Mors, O. N., HOUGAARD, D. M., Mortensen, P. B., et al. (2020) · Human Genetics · doi:10.1007/s00439-020-02140-8 · Cited by 16
Chassaing, M., Boudaud, N., Belliot, G., Estienney, M., Majou, D., de Rougemont, A., & Gantzer, C. (2020) · Food Microbiology · doi:10.1016/j.fm.2020.103594 · Cited by 18
Strain-specific interaction of a GII.10 Norovirus with HBGAs
Jin, M., Tan, M., Xia, M., Wei, C., Huang, P., Wang, L., Zhong, W., Duan, Z., & Jiang, X. (2015) · Virology · doi:10.1016/j.virol.2014.12.039 · Cited by 16
Immunology of Norovirus Infection
León, J. S., Souza, M. B. L. D., Wang, Q., Smith, E. R., Saif, L. J., & Moe, C. L. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8412-6_9 · Cited by 16
Blood group antigen expression is involved in C. albicans interaction with buccal epithelial cells
Everest‐Dass, A., Kolarich, D., Pascovici, D., & Packer, N. H. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9726-7 · Cited by 17
Afolayan, O., Webb, C. C., & Cannon, J. L. (2015) · Food and Environmental Virology · doi:10.1007/s12560-015-9219-z · Cited by 16
Noroviruses and Other Caliciviruses
Dolin, R., & Treanor, J. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00175-2 · Cited by 19
ABO blood groups among Coronavirus disease 2019 patients
Alkout, T. A., & Alkout, A. M. (2020) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2020.0048 · Cited by 15
Waterborne Viral Gastroenteritis: An Introduction to Common Agents
Jain, P., & Jain, A. (2013) · Springer eBooks · doi:10.1007/978-81-322-1029-0_4 · Cited by 15
ABO blood groups and the risk of SARS-CoV-2 infection
BULLERDIEK, J., Reisinger, E. C., Rommel, B., & Dotzauer, A. (2022) · PROTOPLASMA · doi:10.1007/s00709-022-01754-1 · Cited by 15
“In contrast, persons with a B histo-blood group antigen had a decreased risk to become infected and to have symptomatic disease (Hutson et al. 2002).”
ResultHao, N., Chen, Y., Xia, M., Tan, M., Liu, W., Guan, X., Jiang, X., Li, X., & Rao, Z. (2014) · Protein & Cell · doi:10.1007/s13238-014-0126-0 · Cited by 15
Carmona‐Vicente, N., Allen, D. J., Rodríguez‐Díaz, J., Iturriza‐Gómara, M., & Buesa, J. (2016) · Virology Journal · doi:10.1186/s12985-016-0538-y · Cited by 17
Jaykus, L., D'Souza, D. H., & Moe, C. L. (2014) · ASM Press eBooks · doi:10.1128/9781555818463.ch24 · Cited by 15
Infectious Disease Outbreaks on Cruise Ships
McCarter, Y. S. (2009) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2009.10.001 · Cited by 16
Tracking emerging pathogens: the case of noroviruses
Duizer, E., & Koopmans, M. (2006) · Elsevier eBooks · doi:10.1533/9781845691394.1.77 · Cited by 17
Sarvestani, S. T., Cotton, B. T., Fritzlar, S., O’Donnell, T. B., & Mackenzie, J. M. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2015.0124 · Cited by 16
Koo, H. S., Lee, M. O., Ku, P. K., Hwang, S. J., Park, D. J., & Baik, H. S. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-6312-4 · Cited by 14
A non-human primate model for human norovirus infection
Rimkutė, I., Chaimongkol, N., Woods, K. D., Nagata, B. M., Darko, S. W., Gudbole, S., Henry, A. R., Sosnovtsev, S. V., Olia, A. S., Verardi, R., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01585-7 · Cited by 15
“Human susceptibility to human noroviruses is closely related to HBGAs 19,25,35,36 .”
Wang, X., Wang, S., Zhang, C., Zhou, Y., Xiong, P., Liu, Q., & Huang, Z. W. (2018) · Viruses · doi:10.3390/v10010027 · Cited by 18
Martella, V., Pinto, P., & Buonavoglia, C. (2011) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2011.08.002 · Cited by 14
With a Little Help from my Enteric Microbial Friends
Berkhout, B. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00030 · Cited by 13
ABO(H) and Lewis blood group substances and disease treatment
Liu, J., & Wang, D. (2022) · Transfusion Medicine · doi:10.1111/tme.12820 · Cited by 11
Binding-Based RT-qPCR Assay to Assess Binding Patterns of Noroviruses to Shellfish
Langlet, J., Kaas, L., & Greening, G. E. (2015) · Food and Environmental Virology · doi:10.1007/s12560-015-9180-x · Cited by 14
An Unknown Risk Factor for Sepsis in Very Low Birth Weight Preterms: ABO Blood Groups (BGaPS Study)
Çakır, U., Tayman, C., & Büyüktiryaki, M. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-1700864 · Cited by 13
Tenge, V. R., Murakami, K., Salmen, W., Lin, S., Crawford, S. E., Neill, F. H., Prasad, B. V. V., Atmar, R. L., & Estes, M. K. (2021) · Viruses · doi:10.3390/v13060998 · Cited by 14
Self-citation
Metadata
- Authors
- Hutson, A. M., Atmar, R. L., Graham, D. Y., & Estes, M. K.
- Affiliations
- Baylor College of Medicine (US)
- United States Department of Veterans Affairs (US)
- Corresponding author
- Estes, Mary K.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05
- Volume
- 185
- Issue
- 9
- Pages
- 1335-1337
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2570519422
- Cited by
- 487
- References
- 19
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 6 · 2023: 11 · 2022: 18 · 2021: 28 · 2020: 22 · 2019: 23 · 2018: 9 · 2017: 16 · 2016: 31 · 2015: 29 · 2014: 31 · 2013: 25 · 2012: 24
- FWCI
- 13.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5m01rr000350-28, 5u01ai030448-02)
- National Cancer Institute (CA-09197)
- National Institute of Allergy and Infectious Diseases (AI-30448)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK56338, R21DK058955, DK-58955, P30DK056338)
- National Center for Research Resources (RR-00350)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- Norwalk virus, ABO blood group system, infection susceptibility, symptomatic disease, viral gastroenteritis, genetic risk factors, blood group O, blood group B, clinical challenges
- MeSH terms
- ABO Blood-Group System, Disease Susceptibility, Gastroenteritis, Humans, Norwalk virus, Phenotype, Caliciviridae Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.